Mometasone topical - Almirall

Drug Profile

Mometasone topical - Almirall

Alternative Names: Frondava; Ivoxel; LAS-41002; Mometasone furoate - Almirall; Monovo; Mundoson; Mundoson Fluido

Latest Information Update: 20 May 2017

Price : $50

At a glance

  • Originator Laboratorios Almirall
  • Developer Almirall S.A.
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Glucocorticoids; Pregnadienediols; Skin disorder therapies
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Skin disorders

Most Recent Events

  • 10 May 2017 No recent reports on development identified - Registered for Skin disorders in Luxembourg, Spain, France and United Kingdom (Topical, ointment)
  • 10 May 2017 No recent reports on development identified - Registered for Skin disorders in Spain, Luxembourg and United Kingdom (Topical, cream)
  • 10 May 2017 No recent reports on development identified - Registered for Skin disorders in Sweden, Norway, Luxembourg, Finland, Denmark and United kingdom (Topical, cutaneous emulsion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top